Pharmaceutical Division
Propelled by our strong commitment to excellence, the Group is involved in various segments of the pharmaceutical value chain including research and development, manufacturing of generic drugs and medical devices, logistics and distribution, sales and marketing, as well as community pharmacy.
As the world is gripped by the onslaught of the COVID-19 pandemic, we were able to play a critical role in protecting the nation with our capabilities and expertise in supplying, as well as fill-finish manufacturing the Sinovac COVID-19 vaccine for Malaysia. Our partnership with Sinovac Life Sciences Co Ltd did not only mark a milestone for Pharmaniaga but also for the nation, as this is the first human vaccine to be filled and finished locally.
We have also embarked on a Halal vaccine manufacturing project which will begin operating by 2024. This pioneer initiative will generate multiple spillover benefits which include developing a sustainable vaccine supply chain for the nation, in addition to positioning Malaysia as a global vaccine manufacturer.

